{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifuxe73r3phuge3cdbl3wwjcn6etv3wjnxi564jfbazxywqy27bmu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mlc555q4mxw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihvibwr5gqkkzw7uofgzjhzmzzw5yqen3nxyjetyebuxbfcaprd5e"
    },
    "mimeType": "image/jpeg",
    "size": 76545
  },
  "path": "/news/2026-05-combination-therapy-stem-cell-derived.html",
  "publishedAt": "2026-05-07T16:00:12.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak or too slow to be effective. Recently, a type of immune cell called invariant natural killer T (iNKT) cells has attracted attention because of their ability to act as coordinators of immune responses, rapidly activating and rallying other immune cells to fight cancer.",
  "title": "Combination therapy with stem cell-derived immune cells boosts anti-cancer response"
}